AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $64,251 | $50,143 | $34,421 | $33,025 |
| % Growth | 28.1% | 45.7% | 4.2% | – |
| Cost of Goods Sold | $9,094 | $7,780 | $6,041 | $6,104 |
| Gross Profit | $55,157 | $42,363 | $28,380 | $26,921 |
| % Margin | 85.8% | 84.5% | 82.4% | 81.5% |
| R&D Expenses | $20,360 | $20,821 | $13,857 | $15,669 |
| G&A Expenses | $33,195 | $28,334 | $23,330 | $20,946 |
| SG&A Expenses | $91,390 | $65,625 | $45,243 | $37,213 |
| Sales & Mktg Exp. | $58,195 | $37,291 | $21,913 | $16,267 |
| Other Operating Expenses | $0 | -$1,428 | -$3,215 | -$843 |
| Operating Expenses | $111,750 | $85,018 | $55,885 | $52,039 |
| Operating Income | -$56,593 | -$42,655 | -$27,505 | -$25,118 |
| % Margin | -88.1% | -85.1% | -79.9% | -76.1% |
| Other Income/Exp. Net | -$5,198 | $7,340 | $876 | $18 |
| Pre-Tax Income | -$61,791 | -$35,315 | -$26,629 | -$25,100 |
| Tax Expense | $54 | $66 | $36 | $42 |
| Net Income | -$61,845 | -$35,381 | -$26,665 | -$25,142 |
| % Margin | -96.3% | -70.6% | -77.5% | -76.1% |
| EPS | -2.39 | -1.4 | -1.57 | -1.03 |
| % Growth | -70.7% | 10.8% | -52.4% | – |
| EPS Diluted | -2.39 | -1.4 | -1.57 | -1.03 |
| Weighted Avg Shares Out | 25,883 | 25,331 | 25,000 | 24,356 |
| Weighted Avg Shares Out Dil | 25,883 | 25,331 | 25,000 | 24,356 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $24 | $0 |
| Interest Expense | $5,361 | $1,143 | $0 | $29 |
| Depreciation & Amortization | $1,126 | $632 | $568 | $673 |
| EBITDA | -$55,304 | -$33,540 | -$26,045 | -$24,403 |
| % Margin | -86.1% | -66.9% | -75.7% | -73.9% |